A systematic review and meta-analysis indicate that serum OPG levels are higher in PCa patients with bone metastasis, compared to PCa patients without bone metastasis and healthy controls, while the latter two groups showed no difference in OPG levels44. This evidence concerns the gene TNFRSF11B and posterior cortical atrophy.